WaferGen Raises $6.2M in Private Financings | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems has raised gross proceeds of approximately $6.2 million through a series of private placements between June 16 and Aug. 31, the firm said today.

The publicly traded maker of gene expression and genotyping systems said that it issued roughly 5 million shares of common stock at a price of $1.25 per share, along with warrants to purchase 1,502,700 shares of common stock, at an exercise price of $2 per share. The warrants have a five-year term, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.